{
  "id": "OPM-2025-0004-19677",
  "title": "Comment from Charles Emerson",
  "category": "Agency",
  "analysis": {
    "stance": "Against",
    "themes": [
      "Politicization concerns",
      "Merit-based system concerns"
    ],
    "key_quote": "We urge the administration not to reclassify scientists as policymakers. US leadership in biotechnology and medicine is imperiled by this proposal.",
    "rationale": "The comment opposes the proposed rule by emphasizing the importance of political neutrality in scientific funding and warns against the risks of politicizing science, which aligns with concerns about the integrity of the merit-based system."
  },
  "occurrence_number": 0,
  "duplicate_of": ""
}